ELAB — Elevai Labs Income Statement
0.000.00%
- $9.44m
- $8.50m
- $1.71m
Annual income statement for Elevai Labs, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 10-K |
Standards: | USG | USG | USG | USG |
Status: | Final | Final | Final | Final |
Revenue | ||||
Total Revenue | 0 | 0.001 | 0.766 | 1.71 |
Cost of Revenue | ||||
Gross Profit | 0 | 0.001 | 0.447 | 1.13 |
Selling / General / Administrative Expenses | ||||
Research And Development | ||||
Depreciation and Amortization | ||||
Unusual Expense / Income | ||||
Total Operating Expenses | 0.13 | 0.786 | 2.56 | 5.93 |
Operating Profit | -0.13 | -0.785 | -1.79 | -4.22 |
Gain / Loss on Sale of Assets | ||||
Total Net Non Operating Interest Income / Expense | ||||
Net Income Before Taxes | -0.13 | -0.785 | -1.8 | -4.3 |
Net Income After Taxes | -0.13 | -0.785 | -1.8 | -4.3 |
Net Income Before Extraordinary Items | ||||
Net Income | -0.13 | -0.785 | -1.8 | -4.3 |
Income Available to Common Shareholders Excluding Extraordinary Items | ||||
Income Available to Common Shareholders Including Extraordinary Items | ||||
Diluted Net Income | -0.13 | -0.785 | -1.8 | -4.3 |
Diluted Weighted Average Shares | ||||
Basic EPS Including Extraordinary Items | ||||
Diluted EPS Including Extraordinary Items | ||||
Diluted EPS Excluding Extraordinary Items | ||||
Normalised Income Before Taxes | ||||
Normalised Income After Taxes | ||||
Normalised Income Available to Common Shareholders | ||||
Diluted Normalised EPS | -0.007 | -0.045 | -0.104 | -0.222 |
Dividends per Share |